Johnson & Johnson Pledges $55 Billion for U.S. Manufacturing Expansion
Johnson & Johnson will raise U.S. investments by 25% to $55 billion over four years and construct four manufacturing plants, including sites in Wilson, NC and Holly Springs, NC. The company also earmarked over $1 billion for a new cell therapy facility in Pennsylvania as a hedge against proposed 100% drug import tariffs.
1. Proposed 100% Drug Import Tariff
The U.S. administration is considering a 100% tariff on imported branded and patented medicines to be enforced unless manufacturers ramp up domestic production. This proposal has prompted major drugmakers to accelerate U.S. construction projects and secure grace periods by committing to increased local investment.
2. Johnson & Johnson's $55 Billion U.S. Commitment
Johnson & Johnson plans to boost its U.S. investment by 25% to $55 billion over the next four years, with four new plants slated in Wilson, North Carolina and at Fujifilm Biotechnologies' Holly Springs site among others. The company also allocated over $1 billion for a new cell therapy manufacturing facility in Pennsylvania as part of its long-term domestic expansion strategy.